Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion type Assertion NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_head.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion description "[Introduction of synthetic miR-593* suppressed PLK1 expression by 69-73%, reduced cell proliferation (p = 0.008) and increased cell proportion of G2/M phase (p = 0.01) in HSA/c (an EC cells), whereas a miR-593* inhibitor upregulated PLK1 expression by 11-55%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_provenance.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion evidence source_evidence_literature NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_provenance.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion SIO_000772 21170987 NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_provenance.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion wasDerivedFrom befree-2016 NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_provenance.
- NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_assertion wasGeneratedBy ECO_0000203 NP860403.RAhxV7x2ej1raDPHWk0YTorNxVPwcT4QGB0bkuWTnZ9Ao130_provenance.